跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OPTI-TEARS ALLERGY - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
OPTI-TEARS ALLERGY
Authorized
STANDARD
OPTI-TEARS ALLERGY
Alcon Canada Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
c4a72e9c90b4d2e0
Company
Alcon Canada Inc
Type
Standard
Approval Details
Approval Id
c4a72e9c90b4d2e0
Drug Approval Canada Name
OPTI-TEARS ALLERGY
Product Name
OPTI-TEARS ALLERGY
Status
Cancelled Post Market
Status Date
2024-02-22
Original Market Date
2017-04-04
Din
02445573
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Ophthalmic
Schedule
OTC
Ahfs
52:32.00
Atc Original
S01GA51 NAPHAZOLINE, COMBINATIONS
Atc Name
s 01 ga 51
Aig Number
0213722002
Company Name
Alcon Canada Inc
Company Address
2665 Meadowpine Blvd, Mississauga, Ontario, Canada, L5N 8C7
Active Ingredients
NAPHAZOLINE HYDROCHLORIDE
0.025 %
PHENIRAMINE MALEATE
0.3 %
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
c4a72e9c90b4d2e0
Type
Standard
Back to Health Canada Approvals